Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099850 · ClinicalTrials.gov registry record
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
A clinical trial of Pancreatitis, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,345
- Enrollment target
- 1
- Study location
NCT03099850 is a study of Pancreatitis that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,345 participants, above the 484-participant average among 17 other Pancreatitis trials with a reported enrollment target (385% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03099850, a study of Pancreatitis, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,345 participants
- Enrollment target
- 1
- Study location
Study Summary
The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCCEED) Study, which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). No patient enrollment will occur at MDACC. All patient recruitment will occur at external sites that are a part of the CPDPC. The data management systems, auditing, and monitoring effort are supported by the MD Anderson Cancer Center Clinical Research Support Center (CRSC). PROCEED is the first study in the USA that is carefully following participants to better understand factors that may be responsible for causing pancreatitis and how it progresses. The study is being conducted at the following 9 major clinical centers across the US: * Baylor College of Medicine * Cedars-Sinai Medical Center * University of Florida * Indiana University * Mayo Clinic * University of Minnesota * Ohio State University * Stanford University * University of Pittsburgh The study is enrolling participants who are at different stages of chronic pancreatitis, including those with no known pancreas disease (controls), and those with abdominal pain, one or more attacks of pancreatitis, or chronic pancreatitis. After enrollment, participants with abdominal pain and pancreatitis are asked to follow-up every year to learn about their symptoms and any changes in the disease. PROCEED investigators plan to use the detailed information they collect to better understand the disease and identify new treatments. "More details and updated information about this study can be found at the study's public website: https://www.cpdpc-research-consortium.org/research- study-cpdpc-16-02-proceed".
Conditions Studied
Interventions
- OTHER Data Management and Monitoring
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,345 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2030-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03099850
The ClinicalTrials.gov registry entry for NCT03099850 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,345 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 484-participant average among 17 other Pancreatitis trials with a reported enrollment target (385% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Data Management and Monitoring is the first listed.
NCT03099850 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03099850 about?
NCT03099850 is a clinical study titled "Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies". The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCCEED) Study, which is part of the NIH U01 funded Consortium fo...
What is the current status of trial NCT03099850?
This trial is currently recruiting. The enrollment target is 2,345 participants. The study started on 2017-02-28. Estimated completion is 2030-06-30.
What conditions does trial NCT03099850 study?
This clinical trial studies the following conditions: Pancreatitis.
What interventions are being tested in trial NCT03099850?
The interventions under investigation include: Data Management and Monitoring (OTHER).
Who is sponsoring clinical trial NCT03099850?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03099850 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
PROMs After Pancreatectomy
RECRUITING
-
Pancreas Registry and High Risk Registry
RECRUITING
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RECRUITING
-
Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.